Literature DB >> 16612392

Endosomal hyperacidification in cystic fibrosis is due to defective nitric oxide-cylic GMP signalling cascade.

Jens F Poschet1, Joseph A Fazio, Graham S Timmins, Wojciech Ornatowski, Elizabeth Perkett, Monica Delgado, Vojo Deretic.   

Abstract

Endosomal hyperacidification in cystic fibrosis (CF) respiratory epithelial cells is secondary to a loss of sodium transport control owing to a defective form of the CF transmembrane conductance regulator CFTR. Here, we show that endosomal hyperacidification can be corrected by activating the signalling cascade controlling sodium channels through cyclic GMP. Nitric oxide (NO) donors corrected the endosomal hyperacidification in CF cells. Stimulation of CF cells with guanylate cyclase agonists corrected the pH in endosomes. Exposure of CF cells to an inhibitor of cGMP-specific phosphodiesterase PDE5, Sildenafil, normalized the endosomal pH. Treatment with Sildenafil reduced secretion by CF cells of the proinflammatory chemokine interleukin 8 following stimulation with Pseudomonas aeruginosa products. Thus, the endosomal hyperacidification and excessive proinflammatory response in CF are in part due to deficiencies in NO- and cGMP-regulated processes and can be pharmacologically reversed using PDE5 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612392      PMCID: PMC1479567          DOI: 10.1038/sj.embor.7400674

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  29 in total

1.  Mechanisms of TLR9 activation.

Authors:  Eicke Latz; Alberto Visintin; Terje Espevik; Douglas T Golenbock
Journal:  J Endotoxin Res       Date:  2004

2.  Cystic fibrosis.

Authors:  Steven M Rowe; Stacey Miller; Eric J Sorscher
Journal:  N Engl J Med       Date:  2005-05-12       Impact factor: 91.245

3.  Hyperacidification of cellubrevin endocytic compartments and defective endosomal recycling in cystic fibrosis respiratory epithelial cells.

Authors:  Jens F Poschet; Jennifer Skidmore; John C Boucher; Aaron M Firoved; Rebecca W Van Dyke; Vojo Deretic
Journal:  J Biol Chem       Date:  2002-01-24       Impact factor: 5.157

4.  Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction.

Authors:  Kenya Honda; Yusuke Ohba; Hideyuki Yanai; Hideo Negishi; Tatsuaki Mizutani; Akinori Takaoka; Choji Taya; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-04-06       Impact factor: 49.962

5.  Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.

Authors:  J F Poschet; J C Boucher; L Tatterson; J Skidmore; R W Van Dyke; V Deretic
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

6.  Biophysical properties and molecular characterization of amiloride-sensitive sodium channels in A549 cells.

Authors:  A Lazrak; A Samanta; S Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-04       Impact factor: 5.464

7.  TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.

Authors:  Catherine M Greene; Tomás P Carroll; Stephen G J Smith; Clifford C Taggart; James Devaney; Siobhan Griffin; Shane J O'neill; Noel G McElvaney
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

8.  Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells.

Authors:  T J Kelley; M L Drumm
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

Review 9.  Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment.

Authors:  Jens Poschet; Elizabeth Perkett; Vojo Deretic
Journal:  Trends Mol Med       Date:  2002-11       Impact factor: 11.951

Review 10.  Assembly of functional CFTR chloride channels.

Authors:  John R Riordan
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

View more
  10 in total

1.  Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease.

Authors:  J L Taylor-Cousar; C Wiley; L A Felton; C St Clair; M Jones; D Curran-Everett; K Poch; D P Nichols; G M Solomon; M T Saavedra; F J Accurso; J A Nick
Journal:  J Cyst Fibros       Date:  2014-11-13       Impact factor: 5.482

2.  Revisiting the role of cystic fibrosis transmembrane conductance regulator and counterion permeability in the pH regulation of endocytic organelles.

Authors:  Herve Barriere; Miklos Bagdany; Florian Bossard; Tsukasa Okiyoneda; Gabriella Wojewodka; Dieter Gruenert; Danuta Radzioch; Gergely L Lukacs
Journal:  Mol Biol Cell       Date:  2009-05-06       Impact factor: 4.138

3.  cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells.

Authors:  Mary E Manson; Deborah A Corey; Nicole M White; Thomas J Kelley
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

Review 4.  Defective organellar acidification as a cause of cystic fibrosis lung disease: reexamination of a recurring hypothesis.

Authors:  Peter M Haggie; A S Verkman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-03-27       Impact factor: 5.464

5.  Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis.

Authors:  Peter M Haggie; A S Verkman
Journal:  J Biol Chem       Date:  2009-01-09       Impact factor: 5.157

6.  Functional vacuolar ATPase (V-ATPase) proton pumps traffic to the enterocyte brush border membrane and require CFTR.

Authors:  Anne M Collaco; Peter Geibel; Beth S Lee; John P Geibel; Nadia A Ameen
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

Review 7.  CFTR and defective endocytosis: new insights in the renal phenotype of cystic fibrosis.

Authors:  François Jouret; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2008-10-07       Impact factor: 3.657

8.  Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity.

Authors:  Wojciech Ornatowski; Jens F Poschet; Elizabeth Perkett; Jennifer L Taylor-Cousar; Vojo Deretic
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 19.456

9.  Potential of anti-inflammatory treatment for cystic fibrosis lung disease.

Authors:  Jennifer L Taylor-Cousar; Kelsey A Von Kessel; Robert Young; David P Nichols
Journal:  J Inflamm Res       Date:  2010-08-10

10.  Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells.

Authors:  Jens F Poschet; Elizabeth A Perkett; Graham S Timmins; Vojo Deretic
Journal:  bioRxiv       Date:  2020-03-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.